Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
HAN

 

 

 

This is an official
CDC HEALTH UPDATE

Distributed via Health Alert Network
Friday, September 03, 2004, 11:22 EDT (11:22 AM EDT)
CDCHAN-00211-2004-09-03-UPD-N

Flow Chart for Management of Potential Contacts of Lassa Fever Patients

This document updates, with appropriate flow charts for management of potential contacts, the below text from CDC Health Advisory #210. Please reference the flowcharts at the end of the text.

Imported Lassa Fever Case in New Jersey

On September 2, 2004, results of laboratory testing performed at the Centers for Disease Control and Prevention (CDC) support a diagnosis of Lassa fever in a 38-year-old man who died in a New Jersey hospital on August 28. The patient had returned to the United States on August 24 after reportedly spending 5 months in Liberia, where Lassa fever is endemic. This is the first report of a travel-related case of Lassa fever in the United States since 1989.

Lassa fever is an acute viral disease caused by Lassa virus, an arenavirus that is found throughout much of western Africa. The incubation period is usually about 10 days (range 6 to 21 days). The illness is characterized by fever, muscle aches, sore throat, nausea, vomiting, and chest and abdominal pain. Most (about 80%) human infections are mild or asymptomatic; in severe cases, hypotension or shock, hemorrhage, seizures, and death may occur. In disease-endemic areas, Lassa fever causes 100,000 to 300,000 human infections and approximately 5,000 deaths each year.

Lassa virus is spread to humans primarily through contact with the excreta of infected rodents. Person-to-person transmission is uncommon and occurs through direct unprotected contact with blood and other body fluids of an infected person. The virus is not spread by casual contact. Although several cases of imported Lassa fever have been reported previously, secondary transmission to other persons has been extremely rare among both travelers and healthcare workers in non-endemic areas.

Interim Guidance for Risk Assessment and Management

As part of the current investigation, CDC is working with the New Jersey Department of Health and Senior Services and other public health authorities to identify persons who might be at increased risk as a result of close contact with the patient or his body fluids. Public health authorities have established the following criteria for persons who might be at risk. As a precaution, a low-risk category for contact tracing and follow-up is defined below.

High risk

· Exposure from a percutaneous injury (e.g., a needlestick or cut with a sharp object) to blood, tissue or other body fluids that are potentially infectious (e.g., urine, vomitus, stool)

· Exposure from direct, unprotected contact with potentially infectious material (e.g., touching vomitus with an ungloved hand)

· Exposure via mucosal exposure (e.g., to eyes, nose, mouth) to splashes or droplets of potentially infectious blood and body fluids or sexual contact with a symptomatic patient.

Low risk

· Sharing a room or seated in a vehicle within 6 feet (i.e., coughing distance) of a potentially infectious patient, without direct contact with potentially infectious material

· Providing routine medical care while using personal protective equipment appropriately

· Routine cleaning and laundry of contaminated linens and surfaces while using personal protective equipment appropriately

· Transport of a potentially infectious patient or specimen without direct contact with potentially infectious material

· Handling of clinical specimens while using personal protective equipment appropriately

Available information regarding the patient's travel itinerary from West Africa is as follows. The patient left Freetown, Sierra Leone, on Astraeus Flight 72, which departed 11:15 pm on August 23, 2004 and arrived at Gatwick Airport in London, England. He then traveled on Continental Flight 29, which departed London Gatwick Airport on August 24 and arrived in Newark, N.J., at 3:20 pm on August 24. CDC is working to obtain the passenger manifests for these flights and will provide passenger seating and contact information for those at risk to state health departments as soon as it is available. CDC also has contacted health officials in the United Kingdom and the World Health Organization about this case.

People who traveled on these flights and who think they may be at risk are advised to monitor their health for 21 days after their travel (i.e., through September 18, 2004). Other people, including health-care workers, who think they might be at risk should monitor their health for 21 days after the last potential exposure. If fever of 101ºF or greater develops, these persons should contact their state or local health departments for further instructions.

This investigation is ongoing. At this time public health authorities are attempting to identify persons at risk for exposure. Persons in New Jersey who believe they may be at risk should contact the New Jersey health department hotline at 1-866-234-0964. Persons residing in other states should contact their state or local health departments. Additional information about Lassa fever and patient management is provided in the flow charts at the end of this document.

Laboratory Diagnostics and Additional Information

Common causes of fever should be included in the differential diagnosis in addition to consideration of Lassa fever as an etiology. Specific diagnostic testing for Lassa fever is available at CDC (phone: 404-639-1115). Additional information about Lassa fever testing is available on the CDC website at http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm. CDC information about infection control is available at http://www.cdc.gov/ncidod/hip/.

For additional information about the case in New Jersey, please see the website of the New Jersey Department of Health and Senior Services http://www.state.nj.us/health/ or contact the health department's hotline at 1-866-234-0964. For more information about Lassa fever, please see the CDC website at http://www.cdc.gov.

The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national and international organizations.

DEPARTMENT OF HEALTH AND HUMAN SERVICES


HAN Message Types
  • Health Alert: Conveys the highest level of importance; warrants immediate action or attention. Example: HAN00001
  • Health Advisory: Provides important information for a specific incident or situation; may not require immediate action. Example: HAN00316
  • Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action. Example: HAN00309
  • Info Service: Provides general information that is not necessarily considered to be of an emergent nature. Example: HAN00319

 

## This Message was distributed to State and Local Health Officers, Public Information Officers, Epidemiologists and HAN Coordinators as well as Clinician organizations ##

You have received this message based upon the information contained within our emergency notification database. If you have a different or additional e-mail or fax address that you would like us to use, please contact your State-based Health Alert Network program at your State or local health department.


Contact Us:
Ready.gov - Prepare. Plan. Stay Informed.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #